Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 7300 participants.

Also called NCT05700877

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 7,300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05700877
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05700877. Randomized; double masking; primary purpose prevention. Start 2023-01-12 (actual); primary completion 2029-01-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes
Acronym
STENO INTEN-CT
Condition
Cardiovascular Diseases
Intervention (Other)
CAC-based treatment strategy
Intervention (Other)
Standard treatment
Lead sponsor
Per Løgstrup Poulsen (class: other)
Collaborator
Odense University Hospital (class: other)

Record details

Record id
cardio:ct-nct05700877
Content hash
5286b29dc65bfcf3aeef7382b8cb9e7d4d48977bbde8ff8efb208f54af2545be